Print Page   |   Contact Us   |   Sign In   |   Join ISBER
Symposium Speakers
Share |

 Dr. Marcos Castellanos

Dr. Marcos Castellanos has been the Operations Manager of the Nottingham Arabidopsis Stock Centre (NASC) since 2008. He has an MSc in Plant Biotechnology for Emerging Economies from the University of Sussex and a PhD in Plant Biotechnology from the University of Nottingham. He is responsible for leading the NASC Team in preserving, curating and distributing diverse seed and other stocks of Arabidopsis thaliana and related species. NASC currently distributes over 120,000 tubes of seed annually to researchers and educators from 60 countries and runs on a mixed economy of grants and cost-recovery. 

 Stephen Hewitt, MD, PhD

Stephen M. Hewitt, M.D., Ph.D., is a Clinical Investigator within the Laboratory of Pathology, National Cancer Institute and serves as head of the Experimental Pathology Laboratory. Stephen received his BA from the Johns Hopkins University, and his MD and PhD degrees from the University of Texas Health Science Center, Houston. He completed his residency in Anatomic Pathology at the NCI. Dr. Hewitt is Editor-in-Chief of the Journal of Histochemistry & Cytochemistry. Dr Hewitt has co-authored over 300 articles and servers on the editorial board of four peer-reviewed journals.

 Dr. David Klurfeld

David Klurfeld has been National Program Leader for Human Nutrition in the Agricultural Research Service of the U.S. Department of Agriculture since 2004. He is responsible for the scientific direction of the intramural human nutrition research conducted by USDA laboratories. Prior to government service, he was Professor and Chairman of the Department of Nutrition & Food Science at Wayne State University in Detroit, Michigan for 12 years. Before that he was on the faculty of The Wistar Institute and the University of Pennsylvania School of Medicine for 15 years.

His research focused on the relationship of diet and prevention of chronic diseases such as cancer, heart disease, and gallstones. Among his scientific discoveries are the first demonstration that red wine consumption resulted in fewer cardiovascular lesions, that the cholesterol-filled cells in human arterial lesions are white blood cells, that reducing calories was more important than reducing fat in the diet for decreasing cancer growth, and a mediator of this last effect was likely IGF-1. Dr. Klurfeld has published more than 200 peer-reviewed articles and book chapters. He has been Associate Editor of the American Journal for Clinical Nutrition for 11 years and is a member of National Institute for Diabetes, Digestive and Kidney Diseases Advisory Council. He is an elected Fellow of the American Society for Nutrition. 

Dr. Klurfeld received his undergraduate degree in general agriculture from Cornell University and both master’s and doctorate degrees in pathology from the Medical College of Virginia. 

 Helen Moore, PhD

Dr. Helen Moore leads the National Cancer Institute’s Biorepositories and Biospecimen Research Branch (BBRB). As Chief she sets the direction and strategic vision for the Branch and oversees several projects related to biobanking, including: The NCI Best Practices for Biospecimen Resources, a foundational document for biobanking in use internationally; a Biospecimen Science research program to develop the evidence for biospecimen best practices; the Biospecimen Research Database, a Web-based Biospecimen Science literature database; research in the ethical, legal, and social implications of biobanking; and biobanking operations for major NCI and NIH programs including the Cancer Moonshot and the NIH Genotype-Tissue Expression (GTEx) project.

 Manuel Muñoz Aguirre, MSc

Manuel Muñoz Aguirre is a PhD candidate in Statistics and Operations Research (Universitat Politècnica de Catalunya) at the Computational Biology for RNA Processing lab at the Centre for Genomic Regulation, in Barcelona, Spain. He holds a BSc. in Cybernetics Engineering and a MSc. in Data Mining and Knowledge Management. His research interest is the development of statistical and machine learning methods to relate transcriptomic variation with human phenotypes. In particular, his current work focuses on celltype deconvolution from human tissue bulk RNAseq, and the application of deep learning methods to extract and quantify information from histopathology images. 

 Prof. Jeroen Raes

Prof. Jeroen Raes (m) is professor at KU Leuven since 2013 and VIB group leader since 2009. His group currently consists of 23 scientists, with expertise in bioinformatics, systems biology, clinical research and microbiology. He has a substantial track record in microbiome research and has been pioneering the analysis and integration of meta-omics datasets (metagenomics, metatranscriptomics, metaproteomics, meta-metabolomics) with environmental, clinical, host omics and dietary data. He was involved in the FP7 MetaHIT and NIH Human Microbiome Project (the latter as only European partner), which laid the foundations for the human microbiome field as it is today. Finally, his lab is performing a wide range of disease-related projects in a.o. IDB, diabetes, cancer, IBS and antibiotics resistance on national (FWO/IWT) funding and develops novel approaches and tools for microbiome research. Jeroen Raes coordinates the Flemish Gut Flora project, a large scale microbiome- focused population cohort in Belgium, and is bioinformatics coordinator in the Tara Oceans project performing large-scale meta-omics analysis of plankton communities.

 Assoc. Prof. Edyta Reszka

Head of the Department of Molecular Genetics and Epigenetics at NIOM, Lodz, Poland. Scientific interests are focused on molecular basis of processes involving Nrf2-based cytoprotective defense and circadian rhythm in cancer; genetic and epigenetic biomarkers in molecular epidemiology studies. Membership: Polish Society of Toxicology (leader of Lodz's division), EUROTOX, Polish Biochemical Society, Working Time Society, Cancer Epigenetics Society. Author and co-author of 61 publications with 156,036 IF score. H index: 15 and 903 citations (WoS). ORCID ID: 0000-0003-2153-4864. 

 Davide Zocco, PhD

Davide Zocco is currently the Head of R&D at Economics Siena (Italy) where he leads the research, development and validation of extracellular-vesicle-(EV)-based diagnostic kits. He actively contributes to the company’s strategy, scouting of new technologies, IP portofolio and market launch of RUO and CE-IVD diagnostic kits. He is author of peer-reviewed publications in high profile journals, including Nature Chemical Biology and American Journal of Pathology. He holds a PhD from University College Dublin (Ireland) and he was a postdoctoral research fellow at Harvard Medical School (USA).
ISBER Head Office, 750 Pender Street, Suite 301, Vancouver, BC V6C 2T7, Canada.   
T: 1-604-484-5693 F: 1-604-874-4378 E: 

©2018 International Society for Biological and Environmental Repositories (ISBER). All rights reserved.
Facebook GooglePlus Twitter